Key Segments:
By Vaccine Type
-
Inactivated Vaccines
-
Modified-Live Vaccines
-
Recombinant & Vector-Based Vaccines
-
Subunit & Nucleic-Acid Vaccines
-
Autogenous & Other Vaccines
By Disease Type
-
Porcine Circovirus Type 2
-
Porcine Reproductive & Respiratory Syndrome
-
Mycoplasma hyopneumoniae
-
Swine Influenza
-
Others
By Route of Administration
-
Intramuscular
-
Oral
-
Intradermal
-
Intranasal
-
Others
By End User
-
Commercial Pig Farms
-
Breeding Farms & Genetic Companies
-
Veterinary Hospitals & Clinics
-
Government Vaccination Programs
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is projected to reach USD 2.27 Billion by 2035.
The market is anticipated to expand at a CAGR of 5.24% during the forecast period.
North America dominated the global Porcine Vaccines Market in 2025 with a 39.00% revenue share.
Inactivated Vaccines accounted for the largest revenue share of 31.00% in 2025.